Please login to the form below

Not currently logged in
Email:
Password:

Selexys

This page shows the latest Selexys news and features for those working in and with pharma, biotech and healthcare.

Novartis buys blood disease specialist Selexys

Novartis buys blood disease specialist Selexys

Novartis has bolstered its portfolio with a deal to buy US company Selexys Pharmaceuticals, which has a drug for sickle cell disease heading for phase III. ... The Swiss pharma major is paying up to $665m for Selexys, including upfront, acquisition and

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch November 2016 Deal Watch November 2016

    Options exercised. The largest deal in our table this month is the acquisition of Selexys Pharmaceuticals by Novartis for $665m in upfront, acquisition and milestone payments. ... Licensor Acquired/ Licensee Acquirer. Product/ Technology. Deal Type.

  • Pharma deals during September 2012 Pharma deals during September 2012

    Last but not least. The final deal under the spotlight this month is Novartis' option to acquire Selexys Pharmaceuticals upon successful phase II studies in SelG1, a humanised mAb targeting ... Dual-affinity re-targeting (DART) platform technology for

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics